Every trade that managers of Stellar Biotechnologies, Inc. disclose to SEDI is tracked on this page. No insider at Stellar Biotechnologies, Inc. has published a filing in the past twelve months. The most recent one dates from 11 March 2019.
Looking back to 2014, when coverage begins, insiders filed no purchases and 12 sales.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 27 declarations
Stellar Biotechnologies, Inc. is a biotechnology company focused on developing products based on marine snail protein. It is listed on the XTSE market.